Synaptic vesicle protein 2A (SV2A) drugs for Epilepsy

2 tracked Synaptic vesicle protein 2A (SV2A) drugs in the Epilepsy race. The class explanation lives on the Synaptic vesicle protein 2A (SV2A) page; the full indication pipeline across every mechanism is on the Epilepsy page.

2 approved / phase 4

Head-to-head evidence: Levetiracetam (Keppra) vs Levetiracetam (Keppra XR)

The roster

← all Synaptic vesicle protein 2A (SV2A) drugs